Fernanda Guarino De Felice
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fernanda Guarino De Felice has a total of 365 co-authors. Here are the top co-authors by number of shared publications:
- Sergio Teixeira Ferreira
Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
25 shared publications - Mychael V. Lourenco
Universidade Federal do Rio de Janeiro
13 shared publications Sergio T. Ferreira
D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
13 shared publicationsFernanda Tovar-Moll
D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
6 shared publicationsJulia R. Clarke
School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
6 shared publications- Leticia Forny-Germano
Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
6 shared publications
Latest Publications
- Open Access
Acute and Chronic High-Intensity Exercise Differentially Regulate the miRNA Biogenesis Pathway in Human Skeletal Muscle
Background/Objectives: MicroRNAs (miRNAs) are key regulators of skeletal muscle adaptation; however, the extent to which exercise modulates the miRNA biogenesis pathway remains poorly understood. To investigate the impact of acute and chronic high-intensity exercise on components of miRNA biogenesis, and whether such changes are reflected in miRNA expression across stages of their biogenesis, we performed secondary analyses of muscle biopsy samples from two previously published studies. Methods: Muscle biopsies were analyzed from the following protocols: nine men and eight women pre- and 3 h post- a bout of high-intensity interval cycling exercise (HIIE), and eleven men and eight women pre- and post- a 6-week period of high-intensity interval training (HIIT) or non-exercise control. mRNA expression of components of miRNA biogenesis including Drosha, Exportin-5, Dicer, and Ago2 were assessed following HIIE using RT-qPCR and their protein abundance was measured following HIIT using Western blotting. Primary (pri-miR-133a1, -133a2, -133b) and mature (miR-133a-3p, -133a-5p, -133b) miRNA expression were quantified following HIIT. Results: An acute bout of HIIE significantly decreased Drosha mRNA (p < 0.05) and resulted in a reduction in Dicer mRNA that approached significance (p < 0.10). Following 6 weeks of HIIT, no significant changes were detected in the protein abundance of Drosha, Exportin-5, Dicer, or Ago2. HIIT did not alter miR-133 expression at either the primary or mature transcript level across all isoforms. Conclusions: This study highlights the complexity of miRNA regulation in skeletal muscle and underscores the need for further research examining the temporal and mechanistic control of miRNA biogenesis in response to exercise.
Open AccessAcute and Chronic High-Intensity Exercise Differentially Regulate the miRNA Biogenesis Pathway in Human Skeletal Muscle
Background/Objectives: MicroRNAs (miRNAs) are key regulators of skeletal muscle adaptation; however, the extent to which exercise modulates the miRNA biogenesis pathway remains poorly understood. To investigate the impact of acute and chronic high-intensity exercise on components of miRNA biogenesis, and whether such changes are reflected in miRNA expression across stages of their biogenesis, we performed secondary analyses of muscle biopsy samples from two previously published studies. Methods: Muscle biopsies were analyzed from the following protocols: nine men and eight women pre- and 3 h post- a bout of high-intensity interval cycling exercise (HIIE), and eleven men and eight women pre- and post- a 6-week period of high-intensity interval training (HIIT) or non-exercise control. mRNA expression of components of miRNA biogenesis including Drosha, Exportin-5, Dicer, and Ago2 were assessed following HIIE using RT-qPCR and their protein abundance was measured following HIIT using Western blotting. Primary (pri-miR-133a1, -133a2, -133b) and mature (miR-133a-3p, -133a-5p, -133b) miRNA expression were quantified following HIIT. Results: An acute bout of HIIE significantly decreased Drosha mRNA (p < 0.05) and resulted in a reduction in Dicer mRNA that approached significance (p < 0.10). Following 6 weeks of HIIT, no significant changes were detected in the protein abundance of Drosha, Exportin-5, Dicer, or Ago2. HIIT did not alter miR-133 expression at either the primary or mature transcript level across all isoforms. Conclusions: This study highlights the complexity of miRNA regulation in skeletal muscle and underscores the need for further research examining the temporal and mechanistic control of miRNA biogenesis in response to exercise.
- Open Access
- 3 March 2026
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (2)
Fibronectin type III domain-containing protein 5/irisin in extracellular vesicles is reduced in older individuals
The progressive accumulation of physiological stress as we age, known as allostatic load, is linked to an increased risk of dementia. Fostering brain resilience through physical exercise can counteract allostatic load and improve adaptation to age-related brain alterations. Fibronectin type III domain-containing protein 5 (FNDC5)/irisin is a neuroprotective exercise-linked hormone found in extracellular vesicles (EV-FNDC5/irisin). Here, we sought to analyse EV-FNDC5/irisin in ageing as a promising biomarker of brain resilience. We measured exercise-associated factors, including EV-FNDC5/irisin, brain-derived neurotrophic factor (BDNF), and cathepsin B in the serum of 31 young (18–28 years) and 19 older subjects (65–79 years). Levels of FNDC5/irisin in serum-derived EVs are markedly reduced in older subjects compared to young (P = 0.004). We report a reduction in nanoparticles isolated from the serum of older participants (P = 0.009). While EV-FNDC5/irisin positively correlates with BDNF in young subjects (Spearman r = 0.40, P = 0.038), this correlation is absent in elderly subjects (Spearman r = −0.25, P = 0.34). This study provides initial evidence that EV-FNDC5/irisin is reduced in older individuals and loses correlation with BDNF. Our identification of peripheral, exercise-linked factors associated with age may inform biomarker discovery and interventions to promote brain resilience.
- 3 March 2026
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (2)
Open AccessFibronectin type III domain-containing protein 5/irisin in extracellular vesicles is reduced in older individuals
The progressive accumulation of physiological stress as we age, known as allostatic load, is linked to an increased risk of dementia. Fostering brain resilience through physical exercise can counteract allostatic load and improve adaptation to age-related brain alterations. Fibronectin type III domain-containing protein 5 (FNDC5)/irisin is a neuroprotective exercise-linked hormone found in extracellular vesicles (EV-FNDC5/irisin). Here, we sought to analyse EV-FNDC5/irisin in ageing as a promising biomarker of brain resilience. We measured exercise-associated factors, including EV-FNDC5/irisin, brain-derived neurotrophic factor (BDNF), and cathepsin B in the serum of 31 young (18–28 years) and 19 older subjects (65–79 years). Levels of FNDC5/irisin in serum-derived EVs are markedly reduced in older subjects compared to young (P = 0.004). We report a reduction in nanoparticles isolated from the serum of older participants (P = 0.009). While EV-FNDC5/irisin positively correlates with BDNF in young subjects (Spearman r = 0.40, P = 0.038), this correlation is absent in elderly subjects (Spearman r = −0.25, P = 0.34). This study provides initial evidence that EV-FNDC5/irisin is reduced in older individuals and loses correlation with BDNF. Our identification of peripheral, exercise-linked factors associated with age may inform biomarker discovery and interventions to promote brain resilience.
- Open Access
- 2 January 2026
- Published by Wiley in Journal of Neurochemistry
- Vol. 170 (1) , e70341
Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers
Microglia are the main innate immune cells residing in the brain parenchyma. Their activation and resulting neuroinflammation have emerged as major pathogenic mechanisms in neurodegenerative disorders, particularly in Alzheimer's disease (AD). The accumulation of amyloid‐β oligomers (AβOs) and microglia activation play crucial roles in the pathogenesis of AD. In a second vein, the development of innate immune memory in response to different stimuli is a vital mechanism that enables microglia to adjust their response to subsequent inflammatory challenges. While there is increasing evidence that repeated bouts of peripheral inflammation lead to training or tolerance in microglia, the impact of tolerance on the inflammatory response induced by AβOs remains to be determined. In this study, we investigated whether lipopolysaccharide (LPS)‐induced tolerance affects microglial responses to AβOs. For that, organotypic hippocampal cultures were repeatedly challenged with LPS before being exposed to AβOs. We measured cytokine levels and evaluated changes in microglial activation and morphology following exposure of cultures to AβOs. A significant decrease in cytokine production was observed when hippocampal slice cultures were repeatedly challenged with LPS. Interestingly, microglial activation and the resulting inflammatory response induced by AβOs were prevented when these cultures had been previously challenged with LPS. Moreover, the changes in microglial morphology and cytokine production resulting from repeated LPS stimulation were associated with reduced activation of nuclear factor kappa B (NF‐κB). These results indicate that preconditioning microglia with LPS induces a physiological immune tolerance response rather than pathological inflammation, which may have implications for developing therapeutic strategies for AD aimed at modulating innate immune memory. image
- 2 January 2026
- Published by Wiley in Journal of Neurochemistry
- Vol. 170 (1) , e70341
Open AccessInnate Immune Tolerance Regulates Microglia Response to Aβ Oligomers
Microglia are the main innate immune cells residing in the brain parenchyma. Their activation and resulting neuroinflammation have emerged as major pathogenic mechanisms in neurodegenerative disorders, particularly in Alzheimer's disease (AD). The accumulation of amyloid‐β oligomers (AβOs) and microglia activation play crucial roles in the pathogenesis of AD. In a second vein, the development of innate immune memory in response to different stimuli is a vital mechanism that enables microglia to adjust their response to subsequent inflammatory challenges. While there is increasing evidence that repeated bouts of peripheral inflammation lead to training or tolerance in microglia, the impact of tolerance on the inflammatory response induced by AβOs remains to be determined. In this study, we investigated whether lipopolysaccharide (LPS)‐induced tolerance affects microglial responses to AβOs. For that, organotypic hippocampal cultures were repeatedly challenged with LPS before being exposed to AβOs. We measured cytokine levels and evaluated changes in microglial activation and morphology following exposure of cultures to AβOs. A significant decrease in cytokine production was observed when hippocampal slice cultures were repeatedly challenged with LPS. Interestingly, microglial activation and the resulting inflammatory response induced by AβOs were prevented when these cultures had been previously challenged with LPS. Moreover, the changes in microglial morphology and cytokine production resulting from repeated LPS stimulation were associated with reduced activation of nuclear factor kappa B (NF‐κB). These results indicate that preconditioning microglia with LPS induces a physiological immune tolerance response rather than pathological inflammation, which may have implications for developing therapeutic strategies for AD aimed at modulating innate immune memory. image
- 1 January 2026
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 51, 1-15
Regulation of PERM1 and select target genes in human skeletal muscle following fasting and exercise
PERM1 has been identified as a key regulator of muscle energy metabolism, contractile function, and mitochondrial biogenesis. To investigate the impact fasting and acute and chronic high-intensity exercise on p38MAPK, pCaMKII, PGC-1α, ERRα, and PERM1 and on PERM1 target genes ( CKMT2, GLUT4, and SIRT3) in human skeletal muscle. We performed secondary analyses of muscle biopsy samples from two previously published studies, and from one unpublished study. Muscle biopsies were analyzed from the following protocols: (1) nine men pre-, during, and post- an 8 h fast with or without 2 h of arm ergometer exercise; (2) nine men and eight women pre- and 3 h post-acute high-intensity interval cycling exercise (HIIE); and (3) eleven men and eight women pre- and post- a 6-week period of high-intensity interval training (HIIT) or nonexercise control. We used RT-PCR and Western blotting to determine the mRNA and protein levels, respectively. Immunolabelling, microscopy, and subcellular fractionation were also performed to assess PERM1 cellular localization. Fasting did not induce detectable changes in the PERM1-related pathways. HIIE significantly increased p-p38MAPK ( p < 0.05, d = 1.27) protein, and PERM1 ( p < 0.05, d = 0.781) and PGC-1α ( p < 0.05, d = 1.51) mRNA. Six weeks of HIIT increased the protein levels of PERM1 isoform 2 ( p < 0.05, ƞ 2 = 0.168) and CKMT2 ( p < 0.05, ƞ 2 = 0.226). PERM1 was localized in the perinuclear region and enriched in the mitochondria. Our results suggest that only some components of PERM1-related pathways are preserved in human skeletal muscle, highlighting the importance of future studies examining PERM1 function in humans.
- 1 January 2026
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 51, 1-15
Regulation of PERM1 and select target genes in human skeletal muscle following fasting and exercise
PERM1 has been identified as a key regulator of muscle energy metabolism, contractile function, and mitochondrial biogenesis. To investigate the impact fasting and acute and chronic high-intensity exercise on p38MAPK, pCaMKII, PGC-1α, ERRα, and PERM1 and on PERM1 target genes ( CKMT2, GLUT4, and SIRT3) in human skeletal muscle. We performed secondary analyses of muscle biopsy samples from two previously published studies, and from one unpublished study. Muscle biopsies were analyzed from the following protocols: (1) nine men pre-, during, and post- an 8 h fast with or without 2 h of arm ergometer exercise; (2) nine men and eight women pre- and 3 h post-acute high-intensity interval cycling exercise (HIIE); and (3) eleven men and eight women pre- and post- a 6-week period of high-intensity interval training (HIIT) or nonexercise control. We used RT-PCR and Western blotting to determine the mRNA and protein levels, respectively. Immunolabelling, microscopy, and subcellular fractionation were also performed to assess PERM1 cellular localization. Fasting did not induce detectable changes in the PERM1-related pathways. HIIE significantly increased p-p38MAPK ( p < 0.05, d = 1.27) protein, and PERM1 ( p < 0.05, d = 0.781) and PGC-1α ( p < 0.05, d = 1.51) mRNA. Six weeks of HIIT increased the protein levels of PERM1 isoform 2 ( p < 0.05, ƞ 2 = 0.168) and CKMT2 ( p < 0.05, ƞ 2 = 0.226). PERM1 was localized in the perinuclear region and enriched in the mitochondria. Our results suggest that only some components of PERM1-related pathways are preserved in human skeletal muscle, highlighting the importance of future studies examining PERM1 function in humans.
- Open Access
- 29 September 2025
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (6) , 2361-2362
Blood biomarkers for Alzheimer’s disease: Key challenges of clinical implementation
- 29 September 2025
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (6) , 2361-2362
Open AccessBlood biomarkers for Alzheimer’s disease: Key challenges of clinical implementation
- Open Access
- 27 August 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (8) , e70209
The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Extracellular vesicles (EVs) are lipid bilayer nano‐ to micro‐sized particles that carry biomolecules, such as proteins, lipids, and genetic material. Their composition depends on the cellular microenvironment and the health status of tissues. EVs are released by different cell types under distinct circumstances, mediating intercellular communication in both physiological and pathological contexts. In Alzheimer's disease (AD), EVs have been shown to influence pathological events, carrying neurotoxins, such as neuroinflammatory factors, pathogenic forms of amyloid‐β, and phosphorylated tau into recipient neurons. This contributes to the propagation of AD pathology and exacerbates neuronal degeneration. However, under physiological conditions, EVs play key roles in maintaining tissue homeostasis. In the central nervous system (CNS), EVs derived from glial cells and neurons modulate synaptic plasticity and neuronal activity. Interestingly, EVs carrying neurotoxin molecules can cross the blood–brain barrier, making them attractive candidates as biomarkers for diagnosis with a minimally invasive approach to assess CNS alterations. Additionally, EVs contribute to the activation of neuroprotective pathways, participating in the periphery‐to‐brain signaling. Notably, alteration of EV content has been further proposed to have potential therapeutic applications. Herein, we summarize the multifaceted role of EVs in AD, emphasizing their role in promoting neuroprotection and exploring their contribution to our understanding of AD pathophysiology.
- 27 August 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (8) , e70209
Open AccessThe Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Extracellular vesicles (EVs) are lipid bilayer nano‐ to micro‐sized particles that carry biomolecules, such as proteins, lipids, and genetic material. Their composition depends on the cellular microenvironment and the health status of tissues. EVs are released by different cell types under distinct circumstances, mediating intercellular communication in both physiological and pathological contexts. In Alzheimer's disease (AD), EVs have been shown to influence pathological events, carrying neurotoxins, such as neuroinflammatory factors, pathogenic forms of amyloid‐β, and phosphorylated tau into recipient neurons. This contributes to the propagation of AD pathology and exacerbates neuronal degeneration. However, under physiological conditions, EVs play key roles in maintaining tissue homeostasis. In the central nervous system (CNS), EVs derived from glial cells and neurons modulate synaptic plasticity and neuronal activity. Interestingly, EVs carrying neurotoxin molecules can cross the blood–brain barrier, making them attractive candidates as biomarkers for diagnosis with a minimally invasive approach to assess CNS alterations. Additionally, EVs contribute to the activation of neuroprotective pathways, participating in the periphery‐to‐brain signaling. Notably, alteration of EV content has been further proposed to have potential therapeutic applications. Herein, we summarize the multifaceted role of EVs in AD, emphasizing their role in promoting neuroprotection and exploring their contribution to our understanding of AD pathophysiology.
- Open Access
- 5 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Podocyte extracellular vesicles and immune mediators as urinary biomarkers in active lupus nephritis
Urinary extracellular vesicles (uEVs) and immune mediators have emerged as potential minimally invasive renal biomarkers. Even though active lupus nephritis (LN) is associated with immune complex deposition, tissue inflammation, and podocyte damage, it remains unclear how these parameters are simultaneously altered in systemic lupus erythematosus (SLE). Thus, we aimed to evaluate uEVs as biomarkers in LN, in association with urinary immune mediators. In this cross-sectional study, uEVs were isolated from SLE patients and healthy donors by differential centrifugation and characterized and/or quantified by electron microscopy, nanoscale flow cytometry, and nanoparticle tracking analysis (NTA). Urinary immune mediators were assessed by a multiplex assay. We included 82 patients (42.6 ± 11.3 years-old, 91.4% female), of whom 56.1% (n = 46) had LN, and 18 healthy donors (37.5 ± 8.2 years-old, 83.3% female). No differences were found for particle size/concentration by NTA, but higher counts of total (P = 0.03) and podocyte-derived (P = 0.01) uEVs were observed in SLE patients, especially in active LN (P = 0.02; P = 0.03). We also identified higher urinary levels of cytokines such as IL-6, IL-8, and CCL-2 according to SLE activity and LN (P < 0.05). Significant correlations were observed between uEVs, immune mediators, R-SLEDAI-2K, proteinuria, and albuminuria in active LN. Lastly, the combinatory analysis of podocyte uEVs, IL-6, IFN-γ, IL-8, uCCL-2 and CCL-3 showed a good predictive power to detect active LN (AUC = 0.88, P = 0.0009). Our results suggest that urinary podocyte-derived uEVs and cytokines are associated with LN activity, which may reflect podocyte injury mediated by inflammation. Thus, the combined application of these biomarkers could help to identify patients with podocyte damage and renal inflammation.
- 5 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Open AccessPodocyte extracellular vesicles and immune mediators as urinary biomarkers in active lupus nephritis
Urinary extracellular vesicles (uEVs) and immune mediators have emerged as potential minimally invasive renal biomarkers. Even though active lupus nephritis (LN) is associated with immune complex deposition, tissue inflammation, and podocyte damage, it remains unclear how these parameters are simultaneously altered in systemic lupus erythematosus (SLE). Thus, we aimed to evaluate uEVs as biomarkers in LN, in association with urinary immune mediators. In this cross-sectional study, uEVs were isolated from SLE patients and healthy donors by differential centrifugation and characterized and/or quantified by electron microscopy, nanoscale flow cytometry, and nanoparticle tracking analysis (NTA). Urinary immune mediators were assessed by a multiplex assay. We included 82 patients (42.6 ± 11.3 years-old, 91.4% female), of whom 56.1% (n = 46) had LN, and 18 healthy donors (37.5 ± 8.2 years-old, 83.3% female). No differences were found for particle size/concentration by NTA, but higher counts of total (P = 0.03) and podocyte-derived (P = 0.01) uEVs were observed in SLE patients, especially in active LN (P = 0.02; P = 0.03). We also identified higher urinary levels of cytokines such as IL-6, IL-8, and CCL-2 according to SLE activity and LN (P < 0.05). Significant correlations were observed between uEVs, immune mediators, R-SLEDAI-2K, proteinuria, and albuminuria in active LN. Lastly, the combinatory analysis of podocyte uEVs, IL-6, IFN-γ, IL-8, uCCL-2 and CCL-3 showed a good predictive power to detect active LN (AUC = 0.88, P = 0.0009). Our results suggest that urinary podocyte-derived uEVs and cytokines are associated with LN activity, which may reflect podocyte injury mediated by inflammation. Thus, the combined application of these biomarkers could help to identify patients with podocyte damage and renal inflammation.
- Open Access
- 4 August 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (8) , e70185
Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise
Dementia and depression are two prevalent disorders that warrant significant attention due to their high prevalence and substantial contribution to the global burden of disease. Depression has a high incidence in the elderly and is considered a risk factor for the development of dementia, being a promising target for dementia prevention strategies. Additionally, dementia and depression share common mechanisms through which they manifest pathologically. This review addresses the potential shared mechanisms between dementia and depression, including hypothalamic–pituitary–adrenal (HPA) axis dysfunction, brain atrophy (mainly hippocampus and prefrontal cortex), cognitive decline, and neuroinflammation. It also explores the therapeutic potential of physical exercise in modulating these shared pathways, highlighting its role as a non‐pharmacological intervention for the treatment and prevention of both disorders. The review also explores the muscle–brain crosstalk and the intracellular pathways through which physical exercise exerts its effects. image
- 4 August 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (8) , e70185
Open AccessShared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise
Dementia and depression are two prevalent disorders that warrant significant attention due to their high prevalence and substantial contribution to the global burden of disease. Depression has a high incidence in the elderly and is considered a risk factor for the development of dementia, being a promising target for dementia prevention strategies. Additionally, dementia and depression share common mechanisms through which they manifest pathologically. This review addresses the potential shared mechanisms between dementia and depression, including hypothalamic–pituitary–adrenal (HPA) axis dysfunction, brain atrophy (mainly hippocampus and prefrontal cortex), cognitive decline, and neuroinflammation. It also explores the therapeutic potential of physical exercise in modulating these shared pathways, highlighting its role as a non‐pharmacological intervention for the treatment and prevention of both disorders. The review also explores the muscle–brain crosstalk and the intracellular pathways through which physical exercise exerts its effects. image
- Open Access
- 1 May 2025
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 46, 101007
Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease
- 1 May 2025
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 46, 101007
Open AccessComparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease
- Open Access
- 12 April 2025
- Published by Elsevier in Frontiers in Neuroendocrinology
- Vol. 77, 101189
Physical activity in Alzheimer’s disease prevention: Sex differences and the roles of BDNF and irisin
- 12 April 2025
- Published by Elsevier in Frontiers in Neuroendocrinology
- Vol. 77, 101189
Open AccessPhysical activity in Alzheimer’s disease prevention: Sex differences and the roles of BDNF and irisin